pre-seed
Stage
1
Investors
About
MEDEA develops sustainable and natural antibacterial solutions using bacteriophages to target and control bacterial pathogens.
Explore MEDEA's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.